APA (7th ed.) Citation

F, H., J, V., H, S., A, R., Z, F., M, A., . . . P, S. (2024). Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma. Journal for immunotherapy of cancer, 12(4), . https://doi.org/10.1136/jitc-2023-008606

Chicago Style (17th ed.) Citation

F, Hornsteiner, et al. "Tumor-targeted Therapy with BRAF-inhibitor Recruits Activated Dendritic Cells to Promote Tumor Immunity in Melanoma." Journal for Immunotherapy of Cancer 12, no. 4 (2024). https://doi.org/10.1136/jitc-2023-008606.

MLA (9th ed.) Citation

F, Hornsteiner, et al. "Tumor-targeted Therapy with BRAF-inhibitor Recruits Activated Dendritic Cells to Promote Tumor Immunity in Melanoma." Journal for Immunotherapy of Cancer, vol. 12, no. 4, 2024, https://doi.org/10.1136/jitc-2023-008606.